Zobrazeno 1 - 10
of 113
pro vyhledávání: '"John, Bergsagel"'
Autor:
Jason Stevenson, Nicholas P. DeGroote, Frank Keller, Katharine E. Brock, D. John Bergsagel, Tamara P. Miller, Patricia Cornwell, Ross Fasano, Satheesh Chonat, Sharon M. Castellino
Publikováno v:
Cancer Reports, Vol 6, Iss 1, Pp n/a-n/a (2023)
Abstract Background Transfusion of blood products is a necessary part of successful delivery of myelosuppressive regimens in pediatric cancer. There is a paucity of literature characterizing outcomes or management of pediatric patients with cancer wh
Externí odkaz:
https://doaj.org/article/cb1f636f561c482583e57023514a9a79
Autor:
Stephanie M. Smith, Himalee S. Sabnis, Rebecca Williamson Lewis, Karen E. Effinger, John Bergsagel, Briana Patterson, Ann Mertens, Kathleen M. Sakamoto, Lidia Schapira, Sharon M. Castellino
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
Abstract Background Targeted anticancer therapies such as BCR-ABL tyrosine kinase inhibitors (TKIs) have improved outcomes for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL). However, littl
Externí odkaz:
https://doaj.org/article/f2ab9f70ca934309a8d50dc404b21711
Autor:
Juhi Jain, Elizabeth P. Weinzierl, Debra Saxe, John Bergsagel, Jason Gotlib, Andreas Reiter, Sunil S. Raikar
Publikováno v:
HemaSphere, Vol 4, Iss 6, p e486 (2020)
Externí odkaz:
https://doaj.org/article/7a74b3d6d388425389e9f07b567c3247
Background Progressive transformation of germinal centers (PTGC) is a rare diagnosis characterized by asymptomatic lymph node enlargement. It has previously been associated with lymphoma, autoimmune conditions, and lymphoproliferative diseases in sma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::070d9a7b2804b9c6be8611220ce0653c
https://doi.org/10.22541/au.166780085.56161975/v1
https://doi.org/10.22541/au.166780085.56161975/v1
Autor:
Jason Stevenson, Nicholas P. DeGroote, Frank Keller, Katharine E. Brock, D. John Bergsagel, Tamara P. Miller, Patricia Cornwell, Ross Fasano, Satheesh Chonat, Sharon M. Castellino
Publikováno v:
Cancer reports (Hoboken, N.J.)REFERENCES.
Transfusion of blood products is a necessary part of successful delivery of myelosuppressive regimens in pediatric cancer. There is a paucity of literature characterizing outcomes or management of pediatric patients with cancer when transfusion is de
Autor:
John Bergsagel, Stephanie M. Smith, Rebecca Williamson Lewis, Kathleen M. Sakamoto, Himalee S. Sabnis, Briana C. Patterson, Sharon M. Castellino, Lidia Schapira, Ann C. Mertens, Karen E. Effinger
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-8 (2021)
BMC Cancer
BMC Cancer
Background Targeted anticancer therapies such as BCR-ABL tyrosine kinase inhibitors (TKIs) have improved outcomes for chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph + ALL). However, little is know
Autor:
Caroline Keenum, Ann C. Mertens, John Bergsagel, Briana C. Patterson, Sharon M. Castellino, Emily A. Silverman, Himalee S. Sabnis, Karen E. Effinger, Rebecca Williamson Lewis
Publikováno v:
British Journal of Haematology. 185:795-799
Publikováno v:
Journal of Pediatric Neurology. 20:113-114
In adults, lymphomas have been associated with paraneoplastic syndromes that cause cranial nerve palsies, polyneuropathies, and paraplegias. These have been less frequently reported in children. We described a pediatric patient who initially presente
Autor:
Nobuko Hijiya, E. Anders Kolb, Henrique Bittencourt, Donna L. Johnston, Uma H. Athale, Briana C. Patterson, Jeffrey R. Andolina, Michael J. Burke, Kirk R. Schultz, Michele S. Redell, John Bergsagel
Publikováno v:
Pediatr Blood Cancer
Chronic myeloid leukemia (CML) accounts for 2-3% of leukemias in children under 15 and 9% in adolescents aged 15-19. The diagnosis and management of CML in children, adolescents, and young adults have several differences compared to that in adults. T
Autor:
Todd M. Cooper, Himalee S. Sabnis, Silvia T. Bunting, John Dallas Scarborough, Sunil S. Raikar, Frank G. Keller, Brent L. Wood, David Wu, John Bergsagel
Publikováno v:
Pediatric Blood & Cancer. 63:1667-1670
Early T-cell precursor acute lymphoblastic leukemia (ETP-ALL) is a subtype of T-acute lymphoblastic leukemia (T-ALL) arising from a primitive precursor. We present a unique case of an infant with ETP-ALL with a missense NRAS mutation in codon 61 (c.1